Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.43 |
| ▸ | GAA | P10253 | 3/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | TP53 | P04637 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 4/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | AVPR1B | P47901 | 1/20 | 0.40 |
| ▸ | PTGER4 | P35408 | 3/20 | 0.37 |
| ▸ | TSHR | P16473 | 4/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.35 |
| ▸ | CASR | P41180 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14601428 | 0.85 | KDM4E (0.54) | KDM4EHSD17B10RECQLALDH1A1GAA | |
| SCHEMBL14601423 | 0.84 | GRIA1 (0.45) | KDM4EHSD17B10ALDH1A1SMN1; SMN2MAPT | |
| SCHEMBL14601416 | 0.82 | KDM4E (0.38) | KDM4EHSD17B10RECQLALDH1A1GAA | |
| SCHEMBL14601427 | 0.82 | ALDH1A1 (0.44) | KDM4EHSD17B10ALDH1A1GAASMN1; SMN2 | |
| SCHEMBL14601419 | 0.81 | KDM4E (0.43) | KDM4EHSD17B10ALDH1A1GAASMN1; SMN2 | |
| SCHEMBL14601418 | 0.80 | JAK2 (0.42) | KDM4EHSD17B10ALDH1A1SMN1; SMN2MAPT | |
| SCHEMBL14601424 | 0.78 | HPGD (0.40) | KDM4EHSD17B10ALDH1A1SMN1; SMN2MAPT | |
| SCHEMBL14601422 | 0.78 | PTGS2 (0.43) | — | |
| SCHEMBL14601420 | 0.78 | KDM4E (0.57) | KDM4EHSD17B10ALDH1A1SMN1; SMN2MAPT | |
| SCHEMBL14601417 | 0.75 | KDM4E (0.38) | KDM4EHSD17B10ALDH1A1SMN1; SMN2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070004713-A1 | Therapeutic benimidazole compounds | ASTRAZENECA AB (SE) | 2007-01-04 | — | — | US | disclosed |
| US-20070004713-A1 | Therapeutic benimidazole compounds | ASTRAZENECA AB (SE) | 2007-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070004713-A1 | Therapeutic benimidazole compounds | ESR2, ESRRA, ESRRB | KDM4E 2356/4885HSD17B10 1302/4885RECQL 2675/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.